Skip to content
Home/Companies/Healthcare/Resistomap
Resistomap

Resistomap

Healthcare·Finland·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Resistomap?

Resistomap is a Finnish Healthcare company, currently owned by Ananda Impact Ventures since 2023.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Ananda Impact Ventures
Investor
Ananda Impact Ventures
Ananda Impact Fund IV · 2022 · Impact

Key facts

HQFinland
SectorHealthcare
StatusActive
Websitewww.resistomap.com

More from Ananda Impact Fund IV

Other portfolio companies in the same fund.

Jua
Active
AI/MLSwitzerland· 2025
Mycolever
Active
IndustrialsGermany· 2025
Nordic Salt Cycle
Active
ClimateTechDenmark· 2025
Pheiron
Pheiron
Active
BiotechGermany· 2025
Pulsetrain
Active
MobilityGermany· 2025
Decade
Active
ClimateTechGermany· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Resistomap?

Resistomap is currently owned by Ananda Impact Ventures, through Ananda Impact Fund IV, since 2023.

When did Ananda Impact Ventures acquire Resistomap?

Ananda Impact Ventures acquired Resistomap in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue